| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/20/2002 | WO2001083793A3 Targeted modification of chromatin structure |
| 06/20/2002 | WO2001083559A3 Production and use of protein variants having modified immunogenecity |
| 06/20/2002 | WO2001083549A3 Novel polypeptides constituting pheromone receptors in rats, cloning and use thereof |
| 06/20/2002 | WO2001083524A3 Rna metabolism proteins |
| 06/20/2002 | WO2001081417A3 Use of taci as an anti-tumor agent |
| 06/20/2002 | WO2001081416A3 Human ion channel and uses thereof |
| 06/20/2002 | WO2001077164A3 Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis |
| 06/20/2002 | WO2001074904A3 G-protein coupled receptors and nucleic acids encoding same |
| 06/20/2002 | WO2001074897A3 Protein amf-1 to amf-10 and nucleic acids encoding the same |
| 06/20/2002 | WO2001073086A3 Method for genetically modifying a plant |
| 06/20/2002 | WO2001072961A3 Novel compounds |
| 06/20/2002 | WO2001072830A3 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction |
| 06/20/2002 | WO2001068863A3 Plant and yeast polynucleotide sequences coding for proteins interacting with geminivirus proteins |
| 06/20/2002 | WO2001068851A3 Polypeptides and nucleic acids encoding same |
| 06/20/2002 | WO2001068698A3 Non-selective cation channel |
| 06/20/2002 | WO2001062298A3 Compositions and methods for treatment of angiogenesis in pathological lesions |
| 06/20/2002 | WO2001060857A3 Compositions useful for regulating parkin gene activity |
| 06/20/2002 | WO2001059131A3 Use of palatinase and trehalulase sequences as nutritive markers in transformed cells |
| 06/20/2002 | WO2001058948A3 USE OF NEUREGULIN-β AS AN INDICATOR AND/OR TARGET |
| 06/20/2002 | WO2001053453A3 Novel bone marrow nucleic acids and polypeptides |
| 06/20/2002 | WO2001053312A8 Novel nucleic acids and polypeptides |
| 06/20/2002 | WO2001051633A3 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 06/20/2002 | WO2001051627A3 Soybean cyst nematode (scn) resistance loci rhg1 and rhg4 |
| 06/20/2002 | WO2001040461A3 Cdna sequence of two interactors fancip4 and fancip5 of the fanconi anaemia proteins of the complementation groups a and c |
| 06/20/2002 | WO2001036448A8 Preparation and composition of peptides useful for treatment of autoimmune and transplant related graft versus host conditions |
| 06/20/2002 | WO2001032693A3 Trp-protein-related mtr1 protein and dna sequence coding therefor |
| 06/20/2002 | WO2001027154A3 Membrane translocating peptide drug delivery system |
| 06/20/2002 | WO2001012659A3 Human dna sequences |
| 06/20/2002 | WO2001009165A8 ACTIVATION OF PEPTIDE PRODRUGS BY hK2 |
| 06/20/2002 | WO2000077233A9 Complement-resistant non-mammalian dna viruses and uses thereof |
| 06/20/2002 | WO2000075333A9 Streptavidin expressed gene fusions and methods of use thereof |
| 06/20/2002 | WO2000072857A9 Fibrin polymer structure |
| 06/20/2002 | WO2000065052A9 Bridge-1, a transcription factor |
| 06/20/2002 | WO2000064935A9 A novel serotonin-gated anion channel |
| 06/20/2002 | WO2000061752A9 Modified complement system regulators |
| 06/20/2002 | WO2000061750A9 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS |
| 06/20/2002 | WO2000061596A8 50 human secreted proteins |
| 06/20/2002 | WO2000052159A9 Methods and reagents for inhibiting proliferation of smooth muscle cells |
| 06/20/2002 | WO2000052158A9 Methods and reagents for inhibiting angiogenesis |
| 06/20/2002 | WO2000050596A9 14273 receptor, a novel g-protein coupled receptor |
| 06/20/2002 | WO2000049871A9 An anti-angiogenic kringle protein and its mutants |
| 06/20/2002 | US20020078478 Nucleotide sequences coding insecticidal proteins; for use in biological pest control |
| 06/20/2002 | US20020078473 Pesticides |
| 06/20/2002 | US20020077470 Cardiac muscle-associated genes |
| 06/20/2002 | US20020077469 DNA encoding orphan SNORF11 receptor |
| 06/20/2002 | US20020077468 Corticotropin-releasing factor2 receptors |
| 06/20/2002 | US20020077467 Mammalian calcitonin-like polypeptide-1 |
| 06/20/2002 | US20020077466 Protein for use in the diagnosis, prevention and treatment of nervous system and cell proliferation, kidney and urogenital disorders |
| 06/20/2002 | US20020077465 Nuceotide sequences coding enzymatic polypeptide for use in the treatment and prevention of inflammation, cancer, muuscle disorders and thrombosis |
| 06/20/2002 | US20020077464 Novel human neurexin-like proteins and polynucleotides encoding the same |
| 06/20/2002 | US20020077462 Nucleotide sequences coding transport protein for use in treatment of nervous system, cardiovascular, muscular, immunological, cell proliferation and differentiation disorders |
| 06/20/2002 | US20020077460 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 06/20/2002 | US20020077459 Enhanced protein thermostability and temperature resistance |
| 06/20/2002 | US20020077458 Nucleotide sequences for use in the diagnosis, treatment and prevention of apoptosis defects |
| 06/20/2002 | US20020077457 Nucleotide sequences coding binding protein for use as diagnostic tools in genetic engineering |
| 06/20/2002 | US20020077454 Therapeutic pore-forming peptides |
| 06/20/2002 | US20020077313 Methods and compositions for the diagnosis and treatment of cancer |
| 06/20/2002 | US20020077309 For diagnosis, prognosis, evaluation of therapies and treatment of pancreatic disorders |
| 06/20/2002 | US20020077298 Anti-fungal peptides |
| 06/20/2002 | US20020077295 For therapy of cranial or cerebral trauma, spinal cord injury, stroke or a demyelinating disease |
| 06/20/2002 | US20020077294 Method of treating blood disorders |
| 06/20/2002 | US20020077289 Angiostatin and endostatin binding proteins and methods of use |
| 06/20/2002 | US20020077288 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 06/20/2002 | US20020077287 28 human secreted proteins |
| 06/20/2002 | US20020077286 Mechanically activated channel blocker |
| 06/20/2002 | US20020077285 Identification and characterization of multiple splice variants of the mu-opioid receptor gene |
| 06/20/2002 | US20020077284 Inhibitors of HIV membrane fusion |
| 06/20/2002 | US20020077283 Blocking interaction of caveolin with a protein in vivo by administering peptide which comprises caveolin scaffolding domain |
| 06/20/2002 | US20020077282 Method for treating cystic fibrosis |
| 06/20/2002 | US20020077281 Fracture healing using pthrp analogs |
| 06/20/2002 | US20020077275 For therapy of central nervous system disorder including Alzheimer's disease, Parkinson's disease, stroke, post-polio syndrome and amyotrophic lateral sclerosis |
| 06/20/2002 | US20020076834 Immunological detection of celiac disease; obtain body fluids, incubate with antibodies, monitor sample for immunological response to the presence of tissue transglutaminases |
| 06/20/2002 | US20020076823 Near infrared chemiluminescent acridinium compounds and uses thereof |
| 06/20/2002 | US20020076809 Potassium channel protein KCNQ5, a new target for diseases of central nervous system and cardiovascular system |
| 06/20/2002 | US20020076808 Use of suppressor tRNA's to regulate cytotoxicity during the production of recombinant gene products |
| 06/20/2002 | US20020076804 Apparatus for detecting preferential cells and particles in a fluid |
| 06/20/2002 | US20020076801 AAV DNA comprising helper virus sequences |
| 06/20/2002 | US20020076799 Compositions and methods for modulating TGF-beta signaling |
| 06/20/2002 | US20020076797 Purified and isolated piwi family genes and gene products and methods using same |
| 06/20/2002 | US20020076794 Mammalian pro-apoptotic Bok genes and their uses |
| 06/20/2002 | US20020076793 Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4 |
| 06/20/2002 | US20020076788 Nucleotide sequences coding enzymatic polypeptide for use as tools in genetic engineering |
| 06/20/2002 | US20020076785 Human polypeptide for use as an antitumor agent |
| 06/20/2002 | US20020076784 Nucleotide sequences coding preferential polypeptide for use in the treatment of brain disorders, infections and viral diseases |
| 06/20/2002 | US20020076780 Novel human ion channel proteins and polynucleotides encoding the same |
| 06/20/2002 | US20020076779 Polypeptide for use in the treatment of cancer |
| 06/20/2002 | US20020076776 Novel TCTS response regulator |
| 06/20/2002 | US20020076775 WRKY transcription factors and methods of use |
| 06/20/2002 | US20020076773 Nucleic acid amplification controls |
| 06/20/2002 | US20020076770 Generating pantothenic acid; obtain microorganism, culture, propagate, recover pantothenic acid |
| 06/20/2002 | US20020076766 Novel glucosaminidase |
| 06/20/2002 | US20020076765 Bovine tumor necrosis factor receptor-1 and methods of use |
| 06/20/2002 | US20020076763 Production of a multimeric protein by cell fusion method |
| 06/20/2002 | US20020076762 Polypeptide for use in the diagnosis, prevention, and treatment of developmental, cell proliferative, and immunological disorder |
| 06/20/2002 | US20020076761 Polypeptides for use in human therapeutics and diagnostics |
| 06/20/2002 | US20020076760 G-protein coupled receptor HNFDS78 polypeptides |
| 06/20/2002 | US20020076759 Cloning of vertebrate pheromone receptors and uses thereof |
| 06/20/2002 | US20020076758 Polypeptide |
| 06/20/2002 | US20020076757 Nucleotide sequences for use in the treatment of tumors; antitumor agents; antiproliferative agents |
| 06/20/2002 | US20020076756 Nucleotide sequences coding polypeptide for use in treatment of cancer and inflammation; for use as wound healing agent |